Nephros Inc (NEPH): Get ready 510k with FDA fixing to be app...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	85
Posts	8542
Boards Moderated	3
Alias Born	02/21/2014

seven-up

Re: None

Tuesday, 03/08/2016 6:25:57 PM

Tuesday, March 08, 2016 6:25:57 PM

Get ready 510k with FDA fixing to be approved

IT IS WHAT IT IS NOTHING ELSE

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent NEPH News

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/07/2024 09:15:00 PM
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 02/29/2024 09:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:48:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:48:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:48:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:17:43 PM
Nephros Announces Results for Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/08/2023 09:15:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:00:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:05:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:30:14 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:29:28 PM
Nephros Hires Judy Krandel as Chief Financial Officer • GlobeNewswire Inc. • 11/01/2023 11:30:00 AM
Nephros Schedules Third Quarter 2023 Financial Results Conference Call • GlobeNewswire Inc. • 10/25/2023 11:30:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 08:15:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 08:15:27 PM
Nephros Announces Results for Quarter Ended June 30, 2023 • GlobeNewswire Inc. • 08/09/2023 08:15:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:00:51 PM
Nephros Schedules Second Quarter 2023 Financial Results Conference Call • GlobeNewswire Inc. • 07/26/2023 11:30:00 AM
Nephros Announces Results for Quarter Ended March 31, 2023 • GlobeNewswire Inc. • 05/10/2023 08:15:00 PM
Nephros Announces CEO Retirement and Succession Plan • GlobeNewswire Inc. • 05/08/2023 11:30:00 AM

More NEPH News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover